XML 133 R119.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information - Revision of Previously Issued Financial Statements (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense $ 29.4 $ 30.2 $ 29.3 $ 30.0 $ 34.4 $ 43.1 $ 28.6 $ 39.7 $ 118.9 $ 145.8 $ 163.9  
Deferred income tax assets 42.9       34.4       42.9 34.4    
Total assets [1] 5,175.0       4,864.5       5,175.0 4,864.5    
Encompass Health shareholders’ equity 1,276.7       1,152.5       1,276.7 1,152.5    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1,557.0       1,395.4       1,557.0 1,395.4 910.6 $ 765.4
Liabilities and Equity 5,175.0       4,864.5       5,175.0 4,864.5    
Income from continuing operations 46.2 109.4 113.0 105.7 101.5 85.2 79.2 84.7 374.3 350.6 318.1  
Net income 47.7 109.3 113.2 105.2 101.3 85.1 79.4 84.4 375.4 350.2 318.1  
Net income attributable to Encompass Health 28.1 $ 88.6 $ 91.8 $ 83.8 75.4 $ 65.9 $ 63.0 $ 66.8 292.3 271.1 247.6  
Comprehensive income                 375.4 350.1 318.1  
Comprehensive income attributable to Encompass Health                 292.3 271.0 247.6  
As Reported [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense         49.2         160.6    
Deferred income tax assets         63.6         63.6    
Total assets [1]         4,893.7         4,893.7    
Encompass Health shareholders’ equity         1,181.7         1,181.7    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         1,424.6         1,424.6 928.7 779.3
Liabilities and Equity         4,893.7         4,893.7    
Income from continuing operations         86.7         335.8    
Net income         86.5         335.4    
Net income attributable to Encompass Health         60.6         256.3    
Comprehensive income                   335.3    
Comprehensive income attributable to Encompass Health                   256.2    
Adjustment [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense         (14.8)         (14.8)    
Deferred income tax assets         (29.2)         (29.2)    
Total assets [1]         (29.2)         (29.2)    
Encompass Health shareholders’ equity         (29.2)         (29.2)    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         (29.2)         (29.2) (18.1) $ (13.9)
Liabilities and Equity         (29.2)         (29.2)    
Income from continuing operations         14.8         14.8    
Net income         14.8         14.8    
Net income attributable to Encompass Health         14.8         14.8    
Comprehensive income                   14.8    
Comprehensive income attributable to Encompass Health                   14.8    
Encompass Health Corporation [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense                 (70.5) (105.0) (91.1)  
Deferred income tax assets 47.9       68.2       47.9 68.2    
Total assets 3,758.6       3,652.0       3,758.6 3,652.0    
Encompass Health shareholders’ equity 1,276.7       1,152.5       1,276.7 1,152.5    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1,276.7       1,152.5       1,276.7 1,152.5    
Liabilities and Equity $ 3,758.6       3,652.0       3,758.6 3,652.0    
Income from continuing operations                 291.2 271.5 247.6  
Net income                 292.3 271.1 247.6  
Net income attributable to Encompass Health                 292.3 271.1 247.6  
Comprehensive income                 292.3 271.0 247.6  
Comprehensive income attributable to Encompass Health                 $ 292.3 271.0 $ 247.6  
Encompass Health Corporation [Member] | As Reported [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense                   (90.2)    
Deferred income tax assets         97.4         97.4    
Total assets         3,681.2         3,681.2    
Encompass Health shareholders’ equity         1,181.7         1,181.7    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         1,181.7         1,181.7    
Liabilities and Equity         3,681.2         3,681.2    
Income from continuing operations                   256.7    
Net income                   256.3    
Net income attributable to Encompass Health                   256.3    
Comprehensive income                   256.2    
Comprehensive income attributable to Encompass Health                   256.2    
Encompass Health Corporation [Member] | Adjustment [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Provision for income tax expense                   (14.8)    
Deferred income tax assets         (29.2)         (29.2)    
Total assets         (29.2)         (29.2)    
Encompass Health shareholders’ equity         (29.2)         (29.2)    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         (29.2)         (29.2)    
Liabilities and Equity         $ (29.2)         (29.2)    
Income from continuing operations                   14.8    
Net income                   14.8    
Net income attributable to Encompass Health                   14.8    
Comprehensive income                   14.8    
Comprehensive income attributable to Encompass Health                   $ 14.8    
[1] Our consolidated assets as of December 31, 2018 and December 31, 2017 include total assets of variable interest entities of $197.5 million and $264.1 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2018 and December 31, 2017 include total liabilities of the variable interest entities of $50.8 million and $52.5 million, respectively. See Note 3, Variable Interest Entities.